Related references
Note: Only part of the references are listed.Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer(INMARC)
Margaret F. Meagher et al.
UROLOGY (2022)
Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States
Jeffrey M. Howard et al.
JAMA NETWORK OPEN (2021)
Black race may be associated with worse overall survival in renal cell carcinoma patients
Harry Anastos et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment
Bimal Bhindi et al.
EUROPEAN UROLOGY (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors
Jeremy M. O'Connor et al.
ONCOLOGIST (2018)
Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials
Jeremy M. O'Connor et al.
JAMA ONCOLOGY (2018)
Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival
Manish I. Patel et al.
CANCER MEDICINE (2017)
Renal cell cancer histological subtype distribution differs by race and sex
Loren Lipworth et al.
BJU INTERNATIONAL (2016)
Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer
Tracy L. Rose et al.
CANCER (2016)
Racial Disparities in Survival Among Patients With Advanced Renal Cell Carcinoma in the Targeted Therapy Era
Tracy L. Rose et al.
CANCER (2016)
Racial disparities in renal cell carcinoma: a single-payer healthcare experience
Abiodun Mafolasire et al.
CANCER MEDICINE (2016)
Survival among Black and White patients with renal cell carcinoma in an equal-access health care system
Jie Lin et al.
CANCER CAUSES & CONTROL (2015)
Temporal Trends and Factors Associated with Systemic Therapy after Cytoreductive Nephrectomy: An Analysis of the National Cancer Database
Marc C. Smaldone et al.
JOURNAL OF UROLOGY (2015)
Gender differences in incidence and outcomes of urothelial and kidney cancer
Ilaria Lucca et al.
NATURE REVIEWS UROLOGY (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: A comorbidity-controlled competing-risks model
Hiten D. Patel et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics
Wong-Ho Chow et al.
CANCER (2013)
Racial difference in histologic subtype of renal cell carcinoma
Andrew F. Olshan et al.
CANCER MEDICINE (2013)
Impact of gender in renal cell carcinoma: An analysis of the SEER database
Monish Aron et al.
EUROPEAN UROLOGY (2008)
Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival
Helen Shi Stafford et al.
JOURNAL OF UROLOGY (2008)
Share Paper
